Dihydro ergotamine mesylate
CAS : 6190-39-2
Ref. 3D-FD21918
1g | 586,00 € | ||
2g | 934,00 € | ||
100mg | 193,00 € | ||
250mg | 311,00 € | ||
500mg | 437,00 € |
Informations sur le produit
- (5'a,10a)-9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione
- (2'Ξ,5'Α,12'Ξ)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (Salt)
- (5'Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (Salt)
- (5'Alpha,10Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman Methanesulfonate (1:1)
- 9,10-Dihydroergotamine mesylate
- Agit
- Angionorm
- Dergotamine
- Detms
- Dhe 45
- Voir d'autres synonymes
- Diergo
- Dihydergot
- Dihydroergotamine Mesilate
- Dihydroergotamine Methanesulfonate
- Dihydroergotamine methanesulphonate
- Dihydroergotamine monomethanesulfonate
- Dihydroergotaminmesilat
- Dihytamine
- Dirgotarl
- Endophleban
- Ergomimet
- Ergont
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-, methanesulfonate (1:1)
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-, monomethanesulfonate (salt)
- Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, methanesulfonate (1:1)
- Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, monomethanesulfonate (salt)
- Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt)
- Ergotonin
- Ikaran
- Mesilate De Dihydroergotamine
- Mesilato De Dihidroergotamina
- Migranal
- Morena
- Orstanorm
- Seglor
- Tonopres
- Verladyn
Dihydroergotamine mesylate is a medication that is used in the treatment of migraines. It belongs to the group of drugs called ergot alkaloids and has been shown to have high values in cerebral metabolism. Dihydroergotamine mesylate has also been shown to have an effect on dopamine levels in human serum, which may be due to its ability to inhibit neuronal death. Dihydroergotamine mesylate is administered intravenously, orally or intramuscularly for the treatment of acute migraine attacks. The drug can also be given rectally for the prevention of chronic migraine episodes. This drug may cause side effects such as nausea, vomiting and dizziness.
Propriétés chimiques
Question d’ordre technique sur : 3D-FD21918 Dihydro ergotamine mesylate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages